Progress in antisense therapeutics

被引：0
|
作者：
Crooke, ST
机构：
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 1998年 / 358卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
SH31
引用
下载
收藏
页码：R204 / R204
页数：1
相关论文
共 50 条
  • [31] Progress in therapeutics
    Lord, FT
    BOSTON MEDICAL AND SURGICAL JOURNAL, 1905, 153 : 697 - 699
  • [32] Antisense therapeutics and the treatment of CNS disease
    Jaeger, LB
    Banks, WA
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 : 1720 - 1727
  • [33] Modification of alternative splicing by antisense therapeutics
    Kole, R
    Vacek, M
    Williams, T
    OLIGONUCLEOTIDES, 2004, 14 (01) : 65 - 74
  • [34] Antisense oligonucleotide therapeutics for human leukemia
    Gewirtz, AM
    CRITICAL REVIEWS IN ONCOGENESIS, 1997, 8 (01): : 93 - 109
  • [35] Antisense oligonucleotides as therapeutics for malignant diseases
    Ho, PTC
    Parkinson, DR
    SEMINARS IN ONCOLOGY, 1997, 24 (02) : 187 - 202
  • [36] 2′-modified oligonucleotides for antisense therapeutics
    Prakash, Thazha P.
    Bhat, Balkrishen
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (07) : 641 - 649
  • [37] Antisense Oligonucleotide Therapeutics for Neurodegenerative Disorders
    Testa, Claudia M.
    CURRENT GERIATRICS REPORTS, 2022, 11 (03) : 19 - 32
  • [38] Synthetic oligonucleotides: The development of antisense therapeutics
    Monteith, DK
    Levin, AA
    TOXICOLOGIC PATHOLOGY, 1999, 27 (01) : 8 - 13
  • [39] Antisense Oligonucleotide Therapeutics for Neurodegenerative Disorders
    Claudia M. Testa
    Current Geriatrics Reports, 2022, 11 : 19 - 32
  • [40] STRATEGIES FOR CHARACTERIZATION OF ANTISENSE THERAPEUTICS AND THEIR METABOLITES
    CUMMINS, L
    LEEDS, J
    WINNIMAN, M
    PAULUS, A
    GRAHAM, M
    CROOKE, R
    GRIFFEY, RH
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 156 - ANYL
12345